Reuters Phial labelled Sputnik V coronavirus disease (COVID-19) vaccine , Mar 24, 2021. REUTERS
Indian drugmaker Dr Reddy s Laboratories Ltd said on Friday it expects to get 36 million doses of Sputnik V COVID-19 vaccine in the next couple of months under its contract with Russia s sovereign wealth fund. );
}
India s catastrophic second wave of the pandemic has led to huge demand for vaccines, which in turn has left the country, the world s biggest vaccine producer, low on stocks. We are in discussions with the Russian Direct Investment Fund (RDIF) to import the vaccine towards the end of May, a senior Dr Reddy s executive said on a post-earnings press conference.
On a consolidated basis, Dr Reddy s Laboratories net profit dropped 28% to Rs 553.50 crore on 7% increase in revenues to Rs 4,728.40 crore in Q4 March 2021 over Q4 March 2020.
Profit before tax jumped 13% to Rs 807.10 crore in Q4 FY21 as against Rs 714.20 crore in Q4 FY20. EBITDA rose 13.15% to Rs 1,133 crore in Q4 FY21 over Q4 FY20. EBITDA margin stood 24% in Q4 FY21 higher than 22.6% in Q4 FY20.
Revenue in the Global Generics (CG) segment rose 6% to 3873.70 crore in Q4 FY21 over Q4 FY20. The YoY growth was driven by branded markets (India and emerging markets), while Europe was partly offset by decline in North America Generics (NAG).
News By JULIA MARI ORNEDO, GMA News
Published May 5, 2021 2:35pm The Department of Health (DOH) on Wednesday assured Parañaque residents that more COVID-19 vaccines are on the way after several people did not get inoculated despite lining up for the rollout of Russia’s Sputnik V. Health Undersecretary Maria Rosario Vergeire said a number of people flocked to the Sputnik V rollout even though the Parañaque government announced that only those with a schedule or part of the vaccination master list would get a jab. The build up caused tensions to rise, with some residents complaining that they were “left hanging” when the doses ran out.
By JOAHNA LEI CASILAO, GMA News
Published May 4, 2021 2:46pm
A vaccinator shows a vial of Sputnik V, the Russian-made vaccine against COVID-19, that will be used on 20 selected frontliners, senior citizens, and persons with comorbidities during a vaccination run at a hotel in Taguig City on Tuesday, May 4, 2021. Similar vaccination drives using Sputnik V were also held in Parañaque and Manila cities. DANNY PATA NEWS ALERT: Manila begins inoculating Sputnik V vaccines to medical frontliners pic.twitter.com/5BVbiXt5Yf Manila Public Information Office (@ManilaPIO) May 4, 2021 The Manila City Government on Tuesday began inoculating its healthcare workers against the coronavirus disease 2019 (COVID-19) with doses of the Russia-made Sputnik V vaccine.
COVID-19 vaccine: Brazil rejects import of Russia s Sputnik V; cites inherent risks, serious defects
Anvisa s five-strong board voted unanimously not to approve the Russian vaccine after technical staff had highlighted inherent risks and serious defects, citing a lack of information guaranteeing its safety, quality and effectiveness
Reuters | April 27, 2021 | Updated 14:33 IST
The Brazilian health regulator Anvisa on Monday rejected importing the Russian-made Sputnik V Covid-19 vaccine requested by state governors battling a deadly second wave of the virus that is battering Latin America s largest nation. Anvisa s five-strong board voted unanimously not to approve the Russian vaccine after technical staff had highlighted inherent risks and serious defects, citing a lack of information guaranteeing its safety, quality and effectiveness.